The incidence of diabetes mellitus has reached epidemic levels in recent years, affecting one in every 10 adults globally in 2021. Ninety percent of these individuals have Type 2 Diabetes (T2D)...
The implementation of glucagon-like peptide-1 (GLP-1)-based drugs for the treatment of obesity has been an incredible advance in the field, enabling up to 25% decreases in body weight in many...
The first glucagon-like peptide-1 (GLP-1)-based therapeutic was approved by Health Canada in 2011 for the treatment of hyperglycemia in patients with Type 2 diabetes. Little was it suspected at...
November is National Diabetes Awareness Month. It therefore timely to consider what diabetes actually is, why we should care, and how it can be treated. Diabetes, or more technically, diabetes...
As we approach the week during which the 2023 Nobel Prizes will be announced (October 2-9, 2023), it is perhaps timely to consider the events that surrounded the first Nobel Prize awarded to a...
